Daunomycin-polypeptide conjugates with antitumor activity

Biochimica et Biophysica Acta - Biomembranes

Volumn 1798, Issue 12, 2010, Pages 2209-2216

  Szabó, Rita ^a   Bánóczi, Zoltán ^a   MezÖ, Gábor ^a   Láng, Orsolya ^b   KÖhidai, László ^b   Hudecz, Ferenc ^a,c  

^a EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c EÖTVÖS LORÁND UNIVERSITY   (Hungary)

Author keywords

Branched polypeptide conjugates; Daunomycin; In vitro biological effect; Leukemia cell lines; Macrophage

Indexed keywords

CELL PENETRATING PEPTIDE; DAUNORUBICIN; OCTAARGININE; POLYPEPTIDE; SCAVENGER RECEPTOR A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL ADHESION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSTASIS; CYTOTOXICITY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG STRUCTURE; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; LEUKEMIA; MACROPHAGE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; TEMPERATURE; ULTRAVIOLET SPECTROPHOTOMETRY;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL-PENETRATING PEPTIDES; DAUNORUBICIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HL-60 CELLS; HUMANS; MACROPHAGES; MICE; TIME FACTORS;

MURINAE;

EID: 77958150632     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2010.07.023     Document Type: Article

References (30)

1. Minotti G., Sarvazyan N. The anthracyclines: when good things go bad. Cardiovasc. Toxicol. 2007, 7:53-55.
2. Hudecz F., Clegg J.A., Kajtár J., Embleton M.J., Szekerke M., Baldwin R.W. Synthesis, conformation, biodistribution, and in vitro cytotoxicity of daunomycin branched polypeptide conjugates. Bioconjug. Chem. 1992, 3:49-57.
3. Duncan R., Kopečkova-Rejmanova P., Strohalm J., Hume I., Cable H.C., Pohl J., Lloyd J.B., Kopecek J. Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro. Br. J. Cancer 1987, 55:165-174.
4. Haisma H.J., Boesjes M., Beerens A.M., van der Strate B.W., Curiel D.T., Plüddemann A., Gordon S., Bellu A.R. Scavenger receptor A: a new route for adenovirus 5. Mol. Pharm. 2009, 6:366-374.
5. Nakase I., Takeuchi T., Tanaka G., Futaki S. Methodological and cellular aspects that govern the internalization mechanisms of arginine-rich cell-penetrating peptides. Adv. Drug Deliv. Rev. 2008, 60:598-607.
6. Futaki S. Membrane-permeable arginine-rich peptides and the translocation mechanisms. Adv. Drug Deliv. Rev. 2005, 57:547-558.
7. Wu G.Y., Wu C.H. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J. Biol. Chem. 1987, 262:4429-4432.
8. Szabó R., Peiser L., Plüddemann A., Böze S.Z., Heinsbroek S., Gordon S., Hudecz F. Uptake of branched polypeptides with poly[l-Lys] backbone by bone-marrow culture-derived murine macrophages: the role of the class a scavenger receptor. Bioconjug. Chem. 2005, 16:1442-1450.
9. Gaál D., Hudecz F. Low toxicity and high antitumour activity of daunomycin via conjugation to an immunopotential amphoteric branched polypeptide. Eur. J. Cancer 1998, 34:155-161.
10. Hudecz F., Reményi J., Szabó R., Kóczán G.Y., MezÖ G., Kovács P., Gaál D. Drug targeting by macromolecules without recognition unit?. J. Mol. Recognit. 2003, 16:288-298.
11. IUPAC-IUB Commission on Biomedical Nomenclature. Eur. J. Biochem. 1984, 138:9-37.
12. Hudecz F., Pimm M.V., Rajnavölgyi É., MezÖ G., Fabra A., Gaál D., Kovács A.L., Horváth A., Szekerke M. Carrier design: new generation of polycationic branched polypeptides containing OH groups with prolonged blood survival and diminished in vitro cytotoxicity. Bioconjug. Chem. 1999, 10:781-790.
13. MezÖ G., Hudecz F., Kajtár J., Szókán G.Y., Szekerke M. The influence of the side-chain sequence on the structure-activity correlations of immunomodulatory branched polypeptides. Synthesis and conformational analysis of new model polypeptides. Biopolymers 1989, 10:1801-1826.
14. Ryser H.J., Shen W.C. Conjugation of methotrexate to poly(l-lysine) increases drug transport and overcomes drug resistance in cultured cells. Proc. Natl. Acad. Sci. U.S.A. 1978, 75:3867-3870.
15. Reményi J., Csík G., Kovács P., Reig F., Hudecz F. The effect of the structure of branched polypeptide carrier on intracellular delivery of daunomycin. Biochem. Biophys. Acta 2006, 1758:280-289.
16. Bánóczi Z., Peregi B., Orbán E., Szabó R., Hudecz F. Synthesis of daunomycin-oligoarginine conjugates and their effect on human leukemia cells (HL-60). ARKIVOC 2008, 140-153.
17. Bánóczi Z., Reményi J., Takeuchi T., Futaki S., Hudecz F. The effect of octaarginine on the translocation of daunomycin-branched polypeptide conjugates. PEPTIDE SCIENCE 2005 2006, 69-72. The Japanese Peptide Society, Osaka, Japan. T. Wakamiya (Ed.).
18. MezÖ G., de Oliveira E., Krikorian D., Feijlbrief M., Jakab A., Tsikaris V., Sakarellos C., Welling-Wester S., Andreu D., Hudecz F. Synthesis and comparison of antibody recognition of conjugates containing herpes simplex virus type 1 glycoprotein D epitope. Bioconjug. Chem. 2003, 14:1260-1269.
19. Whang-Peng J., Leventhal B.G., Adamson J.W., Perry S. The effect of daunomycin on human cells in vivo and in vitro. Cancer 1969, 23:113-121.
20. Gruber B.M., Anuszewska E.L., Roman I., Goździk A., Priebe W., Fokt I. Topoisomerase II alpha expression and cytotoxicity of anthracyclines in human neoplastic cells. Acta Pol. Pharm. 2006, 63:15-18.
21. Hudecz F., Reményi J., Szabó R., Kóczán G.Y., MezÖ G., Kovács P., Gaál D. Drug targeting by macromolecules without recognition unit?. J. Mol. Recognit. 2003, 16:288-298.
22. Kóczán G., Ghoose A.C., Mookerjee A., Hudecz F. Methotrexate conjugate with branched polypeptide influences Leishmania donovani infection in vitro and in experimental animals. Bioconjug. Chem. 2002, 13:518-524.
23. Reményi J., Balázs B., Tóth S., Falus A., Tóth G., Hudecz F. Isomer-dependent daunomycin release and in vitro antitumour effect of cis-aconityl-daunomycin. Biochem. Biophys. Res. Commun. 2003, 303:556-561.
24. Reményi J., Csík G., Kovács P., Reig F., Hudecz F. The effect of the structure of branched polypeptide carrier on intracellular delivery of daunomycin. Biochem. Biophys. Acta 2006, 1758:280-289.
25. MezÖ G., MezÖ I., Pimm M.V., Kajtár J., SeprÖdi J., Teplán I., Kovács M., Vincze B., Pályi I., Idei M., Szekerke M., Hudecz F. Synthesis, conformation and hormone-related in vitro antitumor activity of a gonadotropin-releasing hormone antagonist-branched polypeptide conjugate. Bioconjug. Chem. 1996, 7:642-650.
26. Szabó R., Peiser L., Plüddemann A., BÖze S.Z., Heinsbroek S., Gordon S., Hudecz F. Uptake of branched polypeptides with poly[l-Lys] backbone by bone-marrow culture-derived murine macrophages: the role of the class a scavenger receptor. Bioconjug. Chem. 2005, 16:1442-1450.
27. Peiser L., Gough P.J., Kodama T., Gordon S. Macrophage class A scavenger receptor-mediated phagocytosis of Escherichia coli: role of cell heterogeneity, microbial strain, and culture conditions in vitro. Infect. Immun. 2000, 68:1953-1963.
28. Tung C.-H., Weissleder R. Arginine containing peptides as delivery vectors. Adv. Drug Deliv. Rev. 2003, 55:281-294.
29. Hudecz F., Bánóczi Z., Csík G. Medium-sized peptides as built in carriers for biologically active compounds. Med. Res. Rev. 2005, 25:679-736.
30. Takayama K., Nakase I., Michiue H., Takeuchi T., Tomizawa K., Matsui H., Futaki S. Enhanced intracellular delivery using arginine-rich peptides by the addition of penetration accelerating sequences (Pas). J. Control. Release 2009, 138:128-133.